Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pine & Power Biotech is a private Shanghai-based regenerative biomaterials and surgical products company founded in 2002. The company develops and manufactures bio-surgery products and implantable soft-tissue repair materials, with a focus on fibrin sealants, hernia repair materials, ligament-regeneration implants, and wound-healing biomaterials. Its best-known commercial product is Chuangxuefeng, a rapid-dissolving porcine-source fibrin sealant used for surgical hemostasis and wound closure. Beyond marketed products, the company has clinical-stage device and biomaterial programs for hernia repair, anterior cruciate ligament reconstruction, and diabetic foot ulcer treatment. Overall, Pine & Power operates at the intersection of medical devices, biologics, and regenerative medicine rather than as a traditional therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pine & Power Biotech.